TABLE 2
FROM:
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
A Kalikaki, A Koutsopoulos, M Trypaki, J Souglakos, E Stathopoulos, V Georgoulias, D Mavroudis and A Voutsina
BACK TO ARTICLETable 2. EGFR and K-RAS status in paired primary and metastatic tumours
| EGFR mutation status | EGFR expression | p-EGFR expression | K-RAS mutation status | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case | Primary | Metastasis | Primary | Metastasis | Primary | Metastasis | Primary | Metastasis | Gefitinib | Response |
| 1 | wt | wt | 1+ | 1+ | 0 | 2+ | wt | wt | No | — |
| 2 | wt | wt | 3+ | 3+ | 1+ | 1+ | wt | wt | No | — |
| 3 | wt | wt | 0 | 1+ | 0 | 0 | wt | wt | No | — |
| 4 | wt | wt | 3+ | 2+ | 0 | 1+ | wt | wt | No | — |
| 5 | wt | wt | 0 | 0 | 0 | 0 | wt | wt | No | — |
| 6 | wt | wt | 1+ | 0 | 0 | 0 | wt | wt | No | — |
| 7 | wt | wt | 0 | 1+ | 0 | 0 | wt | wt | No | — |
| 8 | wt | wt | 1+ | 0 | 0 | 0 | G12S | wt | No | — |
| 9 | wt | wt | 1+ | 1+ | 0 | 1+ | wt | G13S | No | — |
| 10 | wt | wt | 2+ | 3+ | 0 | 0 | G12V | G12V | No | — |
| 11 | wt | wt | ND | 2+ | ND | 2+ | wt | G12S | No | — |
| 12 | wt | L692P V717A | 1+ | 0 | ND | 2+ | wt | wt | No | — |
| 13 | wt | T847A | 0 | 0 | 0 | 1+ | wt | wt | No | — |
| 14 | wt | wt | 3+ | 0 | 1+ | 0 | wt | wt | Yes | PD |
| 15 | wt | wt | 0 | 2+ | ND | 2+ | wt | wt | Yes | PD |
| 16 | wt | wt | 0 | 0 | 0 | 2+ | wt | G12A | Yes | PD |
| 17 | L692P | wt | 0 | 1+ | 0 | 0 | wt | wt | Yes | SD |
| 18 | E746V | wt | 0 | 0 | ND | 0 | wt | wt | Yes | SD |
| 19 | G857E | wt | 0 | 0 | 0 | 1+ | wt | wt | Yes | SD |
| 20 | E746-A750 del | E746-A750 del T790M | 2+ | 3+ | 2+ | 0 | wt | wt | Yes | SD |
| 21 | wt | wt | ND | ND | ND | ND | wt | wt | No | — |
| 22 | wt | wt | ND | ND | ND | ND | G12D | wt | Yes | PD |
| 23 | E746-A750 del | wt | ND | ND | ND | ND | G12C | G12C | Yes | SD |
| 24 | wt | wt | ND | ND | ND | ND | wt | wt | No | — |
| 25 | wt | wt | ND | ND | ND | ND | G12C | wt | No | — |
